Abstract:Abstract Objectives Chronic hyperglycemia is considered as an important factor to promote the neurodegenerative process of brain, and the synaptic plasticity as well as heterogeneity of hippocampal cells are thought to be associated with cognitive dysfunction in the early process of neurodegeneration. To date, fibronectin type III domain‐containing protein 5 (FNDC5) has been highlighted its protective role in multiple neurodegenerative diseases. However, the potential molecular and cellular mechanisms of FNDC5 on synaptic plasticity regulation in cognitive impairment (CI) induced by diabetics are still need to known. Methods/Design To investigate the heterogeneity and synaptic plasticity of hippocampus in animals with CI state induced by hyperglycemia, and explore the potential role of FNDC5 involved in this process. Firstly, the single cell sequencing was performed based on the hippocampal tissue from db diabetic mice induced CI and normal health control mice by ex vivo experiments; and then the integrated analysis and observations validation using Quantitative Real‐time PCR, western blot as well as other in vitro studies. Results We observed and clarified the sub‐cluster of type IC spiral ganglion neurons expressed marker genes as Trmp3 and sub‐cluster of astrocytes with marker gene as Atp1a2 in hippocampal cells from diabetic animals induced CI and the effect of those on neuron‐glial communication. We also found that FNDC5\BDNF‐Trk axis was involved in the synaptic plasticity regulation of hippocampus. In high glucose induced brain injury model in vitro, we investigated that FNDC5 significantly regulates BDNF expression and that over‐expression of FNDC5 up‐regulated BDNF expression ( p < 0.05) and can also significantly increase the expression of synapsin‐1 ( p < 0.05), which is related to synaptic plasticity, In addition, the unbalanced methylation level between H3K4 and H3K9 in Fndc5 gene promoter correlated with significantly down‐regulated expression of FNDC5 ( p < 0.05) in the hyperglycemia state. Conclusion The current study revealed that the synaptic plasticity of hippocampal cells in hyperglycemia might be regulated by FNDC5\BDNF‐Trk axis, playing the protective role in the process of CI induced by hyperglycemia and providing a target for the early treatment of hyperglycemia induced cognitive dysfunction in clinic.

[Contributions of impaired adult hippocampal neurogenesis to occurrence and development of diabetic encephalopathy]

Characteristic Metabolic Alterations Identified in Primary Neurons under High Glucose Exposure

Metabonomic profiles delineate potential role of glutamate-glutamine cycle in db/db mice with diabetes-associated cognitive decline

Diabetes Impairs Hippocampal Function Via Advanced Glycation End Product Mediated New Neuron Generation In Animals With Diabetes-Related Depression

High glucose- or AGE-induced oxidative stress inhibits hippocampal neuronal mitophagy through the Keap1-Nrf2-PHB2 pathway in diabetic encephalopathy

Electroacupuncture Improves Learning and Memory Deficits in Diabetic Encephalopathy Rats by Regulating the Nrf2/HO-1 Pathway

Heterogeneity and synaptic plasticity analysis of hippocampus based on db-/- mice induced diabetic encephalopathy

Progress in the Pathogenesis of Diabetic Encephalopathy: The Key Role of Neuroinflammation

Advanced Glycosylation End Products Induced Synaptic Deficits and Cognitive Decline Through ROS-JNK-p53/miR-34c/SYT1 Axis in Diabetic Encephalopathy

Morphological and Pathological Characteristics of Brain in Diabetic Encephalopathy

Advancing the understanding of diabetic encephalopathy through unravelling pathogenesis and exploring future treatment perspectives

Advanced glycation end products induce Aβ1-42 deposition and cognitive decline through H19/miR-15b/BACE1 axis in diabetic encephalopathy

The Impact of Microbiota-Gut-Brain Axis on Diabetic Cognition Impairment

Endoplasmic Reticulum Stress-Mediated Hippocampal Neuron Apoptosis Involved in Diabetic Cognitive Impairment

Diabetic encephalopathy causes the imbalance of neural activities between hippocampal glutamatergic neurons and GABAergic neurons in mice

The integrated analysis and underlying mechanisms of FNDC5 on diabetic induced cognitive deficits

C-peptide and diabetic encephalopathy

Insight into the Role of Adult Hippocampal Neurogenesis in Aging and Alzheimer's Disease

Advanced Glycation End Products Inhibit Neural Stem Cell Differentiation Via Upregualtion of HDAC3 Expression

Autophagy and Diabetic Encephalopathy: Mechanistic Insights and Potential Therapeutic Implications

Resveratrol ameliorates diabetic encephalopathy through PDE4D/PKA/Drp1 signaling